Atara Biotherapeutics, Inc. (ATRA)

Atara Biotherapeutics Statistics

Total Valuation

ATRA has a market cap or net worth of $60.60 million. The enterprise value is $43.31 million.

Market Cap	60.60M
Enterprise Value	43.31M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

ATRA has 5.67 million shares outstanding. The number of shares has increased by 40.73% in one year.

Current Share Class	5.67M
Shares Outstanding	5.67M
Shares Change (YoY)	+40.73%
Shares Change (QoQ)	+21.54%
Owned by Insiders (%)	2.09%
Owned by Institutions (%)	48.12%
Float	4.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.63
Forward PS	1.08
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.43
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.59

Current Ratio	0.59
Quick Ratio	0.44
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-25.01

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-45.03%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$446,396
Profits Per Employee	-$591,822
Employee Count	225
Asset Turnover	0.61
Inventory Turnover	17.54

Taxes

In the past 12 months, ATRA has paid $18,000 in taxes.

Income Tax	18,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.24% in the last 52 weeks. The beta is 0.49, so ATRA's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	-16.24%
50-Day Moving Average	9.14
200-Day Moving Average	12.56
Relative Strength Index (RSI)	51.56
Average Volume (20 Days)	143,944

Short Selling Information

The latest short interest is 636,280, so 11.21% of the outstanding shares have been sold short.

Short Interest	636,280
Short Previous Month	639,155
Short % of Shares Out	11.21%
Short % of Float	13.73%
Short Ratio (days to cover)	7.11

Income Statement

In the last 12 months, ATRA had revenue of $100.44 million and -$133.16 million in losses. Loss per share was -$22.60.

Revenue	100.44M
Gross Profit	-79.93M
Operating Income	-119.41M
Pretax Income	-233.09M
Net Income	-133.16M
EBITDA	-114.25M
EBIT	-119.41M
Loss Per Share	-$22.60

Balance Sheet

The company has $67.19 million in cash and $49.90 million in debt, giving a net cash position of $17.29 million or $3.05 per share.

Cash & Cash Equivalents	67.19M
Total Debt	49.90M
Net Cash	17.29M
Net Cash Per Share	$3.05
Equity (Book Value)	-90.54M
Book Value Per Share	-15.77
Working Capital	-64.12M

Cash Flow

Operating Cash Flow	-94.65M
Capital Expenditures	-200,000
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is -79.58%, with operating and profit margins of -118.88% and -132.58%.

Gross Margin	-79.58%
Operating Margin	-118.88%
Pretax Margin	-132.56%
Profit Margin	-132.58%
EBITDA Margin	-113.75%
EBIT Margin	-118.88%
FCF Margin	-533.33%

Dividends & Yields

ATRA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-40.73%
Shareholder Yield	-40.73%
Earnings Yield	-219.74%
FCF Yield	n/a

Analyst Forecast

The average price target for ATRA is $26.88, which is 151.69% higher than the current price. The consensus rating is "Hold".

Price Target	$26.88
Price Target Difference	151.69%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	77.96%
EPS Growth Forecast (5Y)	-70.21%

Stock Splits

The last stock split was on June 20, 2024. It was a reverse split with a ratio of 0.04:1.

Last Split Date	Jun 20, 2024
Split Type	Reverse
Split Ratio	0.04:1

Scores

ATRA has an Altman Z-Score of -22.45 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-22.45
Piotroski F-Score	3